Ngā hua rapu - Eric Winquist

Whakamahine hua
  1. 1
    Systemic therapy in the curative treatment of head and neck squamous cell cancer: A systematic review

    Systemic therapy in the curative treatment of head and neck squamous cell cancer: A systematic review mā Eric Winquist, Chika Agbassi, Brandon M. Meyers, John Yoo, Kelvin Chan

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Epidermal Growth Factor Receptor Targeted Therapy in Stages III and IV Head and Neck Cancer

    Epidermal Growth Factor Receptor Targeted Therapy in Stages III and IV Head and Neck Cancer mā C. Cripps, Eric Winquist, Michele deVries, Denise Stys‐Norman, Ralph Gilbert

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Plasma osteopontin

    Plasma osteopontin mā Sébastien J. Hotte, Eric Winquist, Larry Stitt, Sylvia M. Wilson, Ann F. Chambers

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy

    OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy mā Wendy A. Teft, Stephen Welch, John Lenehan, Jeremy Parfitt, Yun‐Hee Choi, Eric Winquist, R B Kim

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer

    A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer mā Scott A. Laurie, Lillian L. Siu, Eric Winquist, Andrew W. Maksymiuk, Erica Harnett, Wendy Walsh, Dongsheng Tu, Wendy R. Parulekar

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    An Evaluation Framework for Funding Drugs for Rare Diseases

    An Evaluation Framework for Funding Drugs for Rare Diseases mā Eric Winquist, Chaim M. Bell, Joe T.R. Clarke, Gerald A. Evans, Janet Martin, Mona Sabharwal, Anita Gadhok, Helen Stevenson, Doug Coyle

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit

    Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit mā Lori J. Wirth, Cosimo Durante, Duncan J. Topliss, Eric Winquist, Eyal Robenshtok, Hiroyuki Iwasaki, Markus Luster, Rossella Elisei, Sophie Leboulleux, Makoto Tahara

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion

    Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion mā Katherine S. Virgo, Ethan Basch, D.A. Loblaw, Thomas K. Oliver, R. Bryan Rumble, Michael A. Carducci, Luke T. Nordquist, Mary-Ellen Taplin, Eric Winquist, Eric A. Singer

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study

    Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Can... mā Karin Oechsle, Friedemann Honecker, Tina Cheng, Frank Mayer, Piotr Czaykowski, Eric Winquist, Lori Wood, Martin Fenner, Stephanie Glaesener, J.T. Hartmann, K.N. Chi, Carsten Bokemeyer, Christian Kollmannsberger

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Phase I/II Trial of Erlotinib and Cisplatin in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Princess Margaret Hospital Phase II Consortium and National Cancer Institute of Canada Clinical Trials Group Study

    Phase I/II Trial of Erlotinib and Cisplatin in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Princess Margaret Hospital Phase II Consortium... mā Lillian L. Siu, Denis Soulières, Eric X. Chen, Gregory R. Pond, Soo Chin, P. Francis, Luc Harvey, M. Klein, Wenjiang Zhang, Janet Dancey, Elizabeth A. Eisenhauer, Eric Winquist

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

    A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and nec... mā Antonio Jimeno, Keisuke Shirai, Minsig Choi, Janessa Laskin, Mark D. Kochenderfer, Alexander I. Spira, Vivian Jean M. Cline-Burkhardt, Eric Winquist, Diana F. Hausman, Luke Walker, Rachel Cohen

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Imatinib Mesylate in Patients With Adenoid Cystic Cancers of the Salivary Glands Expressing c-kit: A Princess Margaret Hospital Phase II Consortium Study

    Imatinib Mesylate in Patients With Adenoid Cystic Cancers of the Salivary Glands Expressing c-kit: A Princess Margaret Hospital Phase II Consortium Study mā Sébastien J. Hotte, Eric Winquist, Elizabeth B. Lamont, Mary J. MacKenzie, Everett E. Vokes, Eric X. Chen, Shirley Brown, Gregory R. Pond, Anthony J. Murgo, Lillian L. Siu

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c

    Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer... mā Fred Saad, Sébastien J. Hotte, Scott North, Bernhard J. Eigl, Kim Chi, Piotr Czaykowski, Lori Wood, Michaël Pollak, Scott Berry, Jean‐Baptiste Lattouf, Som D. Mukherjee, Martin Gleave, Eric Winquist

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management

    Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management mā Özgür Mete, Andrée Boucher, Kasmintan A. Schrader, Omar Abdel‐Rahman, Houda Bahig, Cheryl Ho, Olfat Kamel Hasan, Bernard Lemieux, Eric Winquist, Ralph Wong, Jonn Wu, Nicole G. Chau, Shereen Ezzat

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma

    Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma mā Christine Elser, Lillian L. Siu, Eric Winquist, Mark Agulnik, Gregory R. Pond, Soo Chin, P. Francis, R. Cheiken, James J. Elting, Angela McNabola, Dean Wilkie, Oana Petrenciuc, Eric X. Chen

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care

    Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care mā Fiona A. Miller, Robin Z. Hayeems, Jessica Bytautas, Philippe L. Bédard, Scott Ernst, Hal W. Hirte, Sébastien J. Hotte, Amit M. Oza, Albiruni Ryan Abdul Razak, Stephen Welch, Eric Winquist, Janet Dancey, Lillian L. Siu

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract

    Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Car... mā Joaquim Bellmunt, Christine Théodore, T. Demkov, B. K. Komyakov, Lisa Sengeløv, Gedske Daugaard, Armelle Caty, Joan Carles, Agnieszka Jagiełło-Gruszfeld, Oleg Karyakin, François-Michel Delgado, P Hurteloup, Eric Winquist, Nassim Morsli, Yacine Salhi, Stéphane Culine, Hans von der Maase

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer

    Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer mā Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber, Anuradha Jayaram, Eric Winquist, Brigit McLaughlin, David Lu, Martin Fleisher, Sarah Orr, Lori E. Lowes, Amanda Anderson, Yipeng Wang, Ryan Dittamore, Alison L. Allan, Gerhardt Attard, Glenn Heller

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987

    Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Sys... mā Joaquim Bellmunt, Hans von der Maase, Graham M. Mead, Iwona Skoneczna, Maria De Santis, Gedske Daugaard, Andreas Boehle, Christine Chevreau, Luis Paz‐Ares, Leslie R. Laufman, Eric Winquist, Derek Raghavan, Sandrine Marréaud, Sandra Collette, Richard Sylvester, Ronald de Wit

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

    Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 rando... mā Jan B. Vermorken, Jan Stöhlmacher-Williams, Ірина Давиденко, Lisa Licitra, Eric Winquist, Cristian Villanueva, Paolo Foa, Sylvie Rottey, Krzysztof Składowski, Makoto Tahara, Vasant R. Pai, Sandrine Faivre, C. Blajman, Arlene A. Forastiere, B. Stein, Kelly S. Oliner, Zhiying Pan, Bruce Allen Bach

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: